Hybrid cardiac rehabilitation trial (HYCARET): protocol of a randomised, multicentre, non-inferiority trial in South America

被引:9
|
作者
Seron, Pamela [1 ]
Oliveros, Maria J. [1 ]
Marzuca-Nassr, Gabriel N. [2 ]
Lanas, Fernando [1 ]
Morales, Gladys [3 ]
Roman, Claudia [4 ]
Munoz, Sergio R. [5 ]
Saavedra, Nicolas [6 ]
Grace, Sherry L. [7 ,8 ]
机构
[1] Univ La Frontera, CIGES, Internal Med Dept, Temuco, Chile
[2] Univ La Frontera, Internal Med Dept, Temuco, Chile
[3] Univ La Frontera, EPICYN, Publ Hlth Dept, Temuco, Chile
[4] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile
[5] Univ La Frontera, CIGES, Publ Heath Dept, Temuco, Chile
[6] Univ La Frontera, Basic Sci Dept, Temuco, Chile
[7] York Univ, Fac Hlth, Toronto, ON, Canada
[8] Univ Toronto, Univ Hlth Network, KITE & Peter Munk Cardiac Ctr, Toronto, ON, Canada
来源
BMJ OPEN | 2019年 / 9卷 / 10期
关键词
MYOCARDIAL-INFARCTION; PERFORMANCE-MEASURES; PHYSICAL-ACTIVITY; DELIVERY MODEL; PREVENTION; STATEMENT; ASSOCIATION; RECOMMENDATIONS; QUESTIONNAIRE; COUNCIL;
D O I
10.1136/bmjopen-2019-031213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Cardiac rehabilitation (CR) programmes are well established, and their effectiveness and cost-effectiveness are proven. In spite of this, CR remains underused, especially in lower-resource settings such as Latin America. There is an urgent need to create more accessible CR delivery models to reach all patients in need. This trial aims to evaluate if the prevention of recurrent cardiovascular events is not inferior in a hybrid CR programme compared with a standard programme. Method and analysis A non-inferiority, pragmatic, multicentre, parallel (1:1), prospective, randomised and open with blinded endpoint assessment clinical trial will be conducted. 308 patients with coronary artery disease will be recruited consecutively. Participants will be randomised to hybrid or standard rehabilitation programme. The hybrid CR programme includes 10 supervised exercise sessions and individualised lifestyle counselling by a physiotherapist, with a transition after 4-6 weeks to unsupervised delivery via text messages and phone calls. The standard CR consists of 18-22 supervised exercise sessions, as well as group education sessions about lifestyle. Intervention in both groups is between 8 and 12 weeks. The primary outcome is a composite of cardiovascular mortality and hospitalisations due to cardiovascular causes. Secondary outcomes are health-related quality of life, exercise capacity, muscle strength, heart-healthy behaviour, return-to-work, cardiovascular risk factor, adherence, and exercise-related adverse events. The outcomes will be measured at the end of intervention, at 6 months and at 12 months follow-up from recruitment. The primary outcome will be tracked through the end of the trial. Per-protocol and intention-to-treat analysis will be undertaken. Cox regression model will be used to compare primary outcome among study groups. Ethics and dissemination Ethics committees at the sponsor institution and each centre where participants will be recruited approved the study protocol and the Informed Consent. Research findings will be published in peer-reviewed journals; additionally, results will be disseminated among region stakeholders.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Non-inferiority of azathioprine versus β interferons for relapsing-remitting multiple sclerosis: a multicentre randomised trial
    Massacesi, L.
    Tramacere, I.
    Benedetti, M. D.
    Filippini, G.
    La Mantia, L.
    Solari, A.
    Milanese, C.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 187 - 188
  • [22] What is a non-inferiority trial?
    Sedgwick, Philip
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [23] The YOMEGA non-inferiority trial
    Musella, Mario
    Vitiello, Antonio
    LANCET, 2019, 394 (10207): : 1412 - 1412
  • [24] Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial
    Cornelius, Victoria
    Babalis, Daphne
    Carroll, William D.
    Cunningham, Steven
    Fleming, Louise
    Gaillard, Erol
    Gupta, Atul
    Janani, Leila
    Kennington, Erika
    Murray, Clare
    Nagakumar, Prasad
    Roberts, Graham
    Seddon, Paul
    Sinha, Ian
    Streatfield, Claire
    Weir, Elise
    Saglani, Sejal
    BMJ OPEN, 2024, 14 (08):
  • [25] HOspital care versus TELemonitoring in high-risk pregnancy (HOTEL): study protocol for a multicentre non-inferiority randomised controlled trial
    van den Heuvel, Josephus F. M.
    Ganzevoort, Wessel
    De Haan-Jebbink, Jiska M.
    van der Ham, David P.
    Deurloo, Koen L.
    Seeber, Laura
    Franx, Arie
    Bekker, Mireille N.
    BMJ OPEN, 2019, 9 (10):
  • [26] Protocol: a randomised, open label, multicentre, non-inferiority clinical trial in new treatment modalities for cutaneous leishmaniasis caused by Leishmania tropica
    Kamink, S.
    Boota, M.
    Ashraf, S.
    Singh, S.
    Katambula, F.
    Ahmad, B.
    Keus, K.
    Hussein, F.
    Grobusch, M.
    Arana, B.
    Boer, M.
    Ritmeijer, K.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2021, 26 : 71 - 71
  • [27] Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial
    Maddison, Ralph
    Rawstorn, Jonathan Charles
    Stewart, Ralph A. H.
    Benatar, Jocelyne
    Whittaker, Robyn
    Rolleston, Anna
    Jiang, Yannan
    Gao, Lan
    Moodie, Marj
    Warren, Ian
    Meads, Andrew
    Gant, Nicholas
    HEART, 2019, 105 (02) : 122 - 129
  • [28] Reply: The impact of an inappropriate non-inferiority margin in a non-inferiority trial
    Groenewoud, Eva
    Kollen, Boudewijn
    Macklon, Nick
    Cohlen, Ben
    HUMAN REPRODUCTION, 2016, 31 (12) : 2893 - 2893
  • [29] Non-inferiority of a hybrid outpatient rehabilitation: a randomized controlled trial (HIRE, DRKS00028770)
    Richard Albers
    Stella Lemke
    Sebastian Knapp
    Gert Krischak
    Matthias Bethge
    BMC Digital Health, 1 (1):
  • [30] Dosage of pain rehabilitation programmes for patients with chronic musculoskeletal pain: a non-inferiority randomised controlled trial
    Reneman, Michiel F.
    Waterschoot, Franka P. C.
    Burgerhof, Johannes G. M.
    Geertzen, Jan H. B.
    Preuper, Henrica R.
    Dijkstra, Pieter U.
    DISABILITY AND REHABILITATION, 2020, 42 (06) : 814 - 821